Mr Mrs Miss Ms Dr Other

Dr
Fiona
Christie

Senior Patent Attorney

Leeds Office

Chemistry

Telephone. +44(0) 113 233 0100
Email. [email protected]

Experience

Since joining HGF in 2014, Fiona has worked on drafting and prosecuting patent applications in a range of practice areas in the chemical field including pharmaceuticals, physical chemistry and nanomaterials.

Prior to joining HGF, Fiona obtained a First Class MSci in Forensic and Analytical Chemistry from the University of Strathclyde in 2009, during which she undertook a one-year industrial placement at Pfizer.

Fiona then moved to Cambridge University to accept a place on the Nanoscience and Technology Doctoral Training Centre. Fiona's doctoral research involved investigating routes to understanding the aggregation behaviour of insulin through the use of supramolecular chemistry. Following the submission of her thesis, Fiona completed a short research internship at the Ecole Normale Superieure in Paris, France working towards the manipulation of particle deposition in evaporating droplets.

Fiona qualified as a Chartered Patent Attorney and as a European Patent Attorney in 2019.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MSCI

Forensic and Analytical Chemistry, University of Strathclyde, 2009

PHD

Chemistry, University of Cambridge, 2014

POSTGRADUATE DIPLOMA OR CERTIFICATE

PGCert IP, University of Bournemouth

Related News

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article
Event - 16th November 2023

Webinar in cooperation with the BVIZ: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.